Thursday, June 17, 2021

Pricey brain-cancer drug no longer an option under Medicare

Seller of therapy that can cost up to $1,000 a capsule exited federal discount program in January. "It's all greed," one critic said.
https://ift.tt/eA8V8J
from Us - CBSNews.com

0 comments:

Post a Comment